Baduanjin Exercise Prevents post-Myocardial Infarction Left Ventricular Remodeling (BE-PREMIER trial): Design and Rationale of a Pragmatic Randomized Controlled Trial
机构:[1]Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou 510405, China广东省中医院深圳市中医院深圳医学信息中心[2]Department of Critical Care Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, China大德路总院重症医学科大德路总院重症医学科广东省中医院[3]Faculty of Medicine, University of Toronto, University Ave., Toronto M5G 0A4, Canada[4]Physiology & Experimental Medicine, Hospital for Sick Children, University Ave, Toronto M5G 0A4, Canada
Left ventricular (LV) remodeling following myocardial infarction (MI) is an established prognostic factor for adverse cardiovascular events and the leading cause of heart failure. Empirical observations have suggested that Baduanjin exercise, an important component of traditional Chinese Qigong, may exert potential benefits on cardiopulmonary function. However, the impact of a Baduanjin exercise-based cardiac rehabilitation program for patients recovering from a recent MI has yet to be assessed. The aim of this trial is to evaluate the potential role of Baduanjin exercise in preventing the maladaptive progression to adverse LV remodeling in patients post-MI. A total of 110 clinically stable patients following an MI after undergoing successful infarct-related artery reperfusion will be randomly assigned to the Baduanjin exercise group or usual exercise control group. In addition to usual physical activity, participants in the Baduanjin exercise group will participate in a 45 min Baduanjin exercise training session twice a week, for a total of 12 weeks. The primary endpoint will be the percentage change in LV end-diastolic volume index (LVEDVi) assessed using echocardiography from baseline to 6 months. The results of this study may provide novel evidence on the efficacy of Baduanjin exercise therapy in post-MI patients in reversing adverse LV remodeling and improving clinical outcome. Clinical Trials.gov: NCT02693795.
基金:
Postdoctoral Science Foundation
of China (No.2015 M570701), Science Foundation of Guangdong
Province (No.2015 A030310437&2015 A030306049), Foundation from
Department of Science and Technology of Guangdong Province (to
Xiaoxuan Zhang), National Basic Research Program of China (973
Program, 2015CB554400) and National Science Foundation
(No.81473471&81202782&81573708).
基金编号:No.2015 M570701
语种:
外文
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2015]版:
大类|3 区医学
小类|3 区心脏和心血管系统3 区药学
最新[2025]版:
大类|3 区医学
小类|3 区药学4 区心脏和心血管系统
JCR分区:
出版当年[2014]版:
Q2PHARMACOLOGY & PHARMACYQ2CARDIAC & CARDIOVASCULAR SYSTEMS
第一作者机构:[1]Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou 510405, China[2]Department of Critical Care Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, China[4]Physiology & Experimental Medicine, Hospital for Sick Children, University Ave, Toronto M5G 0A4, Canada
共同第一作者:
通讯作者:
通讯机构:[1]Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou 510405, China[2]Department of Critical Care Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, China
推荐引用方式(GB/T 7714):
Mao Shuai,Zhang Xiaoxuan,Shao Biying,et al.Baduanjin Exercise Prevents post-Myocardial Infarction Left Ventricular Remodeling (BE-PREMIER trial): Design and Rationale of a Pragmatic Randomized Controlled Trial[J].CARDIOVASCULAR DRUGS AND THERAPY.2016,30(3):315-322.doi:10.1007/s10557-016-6660-7.
APA:
Mao, Shuai,Zhang, Xiaoxuan,Shao, Biying,Hu, Xiyan,Hu, Yanan...&Zhang, Minzhou.(2016).Baduanjin Exercise Prevents post-Myocardial Infarction Left Ventricular Remodeling (BE-PREMIER trial): Design and Rationale of a Pragmatic Randomized Controlled Trial.CARDIOVASCULAR DRUGS AND THERAPY,30,(3)
MLA:
Mao, Shuai,et al."Baduanjin Exercise Prevents post-Myocardial Infarction Left Ventricular Remodeling (BE-PREMIER trial): Design and Rationale of a Pragmatic Randomized Controlled Trial".CARDIOVASCULAR DRUGS AND THERAPY 30..3(2016):315-322